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The major and essential objective of pre-implanta-
tion development is to establish embryonic and ex-
tra-embryonic cell fates. To address when and how
this fundamental process is initiated in mammals,
we characterize transcriptomes of all individual cells
throughout mouse pre-implantation development.
This identifies targets of master pluripotency regula-
tors Oct4 and Sox2 as being highly heterogeneously
expressed between blastomeres of the 4-cell em-
bryo, with Sox21 showing one of the most heteroge-
neous expression profiles. Live-cell tracking demon-
strates that cells with decreased Sox21 yield more
extra-embryonic than pluripotent progeny. Consis-
tently, decreasing Sox21 results in premature upre-
gulation of the differentiation regulator Cdx2, sug-
gesting that Sox21 helps safeguard pluripotency.
Furthermore, Sox21 is elevated following increased
expression of the histone H3R26-methylase CARM1
and is lowered following CARM1 inhibition, indi-
cating the importance of epigenetic regulation.
Therefore, our results indicate that heterogeneous
gene expression, as early as the 4-cell stage, initiates
cell-fate decisions by modulating the balance of plu-
ripotency and differentiation.INTRODUCTION
When in mammalian development cells first start to differ from
each other and whether these first differences play any role in
cell-fate specification remain key open questions. Inmanymodel
systems, initiation of cell-fate specification stems from heteroge-
neity between the blastomeres of the early embryo, but whether
this might also be the case in mammals remains unknown. The
first cell-fate specification in the mammalian embryo leads to
the separation of embryonic and extra-embryonic lineages.The embryonic lineage is pluripotent and will give rise to the
fetus, while the extra-embryonic lineages will differentiate into
supportive structures critical for embryo implantation and fetal
development, the placenta, and yolk sac (Takaoka and Hamada,
2012; Zernicka-Goetz et al., 2009). How and when these line-
ages start to separate in morphologically homogenous cells
has been very difficult to dissect in mammals. Historically, cells
of the early mouse embryowere considered identical in their abil-
ity to give rise to embryonic or extra-embryonic lineages, due to
the regulative ability of the embryo to compensate for alterations
in cell arrangement (Hillman et al., 1972; Tarkowski, 1959). How-
ever, more recent evidence has suggested that cells as early as
the 4-cell stage become heterogeneous, exhibiting differences in
developmental fate and potential (Bischoff et al., 2008; Piotrow-
ska-Nitsche et al., 2005; Tabansky et al., 2013) and in the activity
of specific cell-fate regulators (Burton et al., 2013; Plachta et al.,
2011; Torres-Padilla et al., 2007). This heterogeneity indicates
the possibility that the breaking of embryo symmetry starts
earlier than expected, prior to differences in cell position and
polarity evident from the 16-cell-stage onward (Fleming, 1987;
Johnson and Ziomek, 1981). However, finding causal links
between this early heterogeneity and later lineage divergence
has proved extremely difficult because the key evidence—differ-
ences in gene expression patterns between individual cells that
regulate cell fate—has, until now, been hard to identify due to
technical limitations.
High-throughput single-cell transcriptomics offers an unbi-
ased approach for understanding the extent, basis, and function
of gene expression variation between seemingly identical cells.
So far, the focus of single-cell studies in the mouse embryo
has been on gene expression patterns that characterize partic-
ular developmental stages or lineages within the blastocyst or
mono versus bi-allelic gene expression (Biase et al., 2014;
Deng et al., 2014; Guo et al., 2010; Shi et al., 2015; Tang et al.,
2011; Xue et al., 2013), rather than on investigating the functional
consequences of heterogeneity within the same embryo for cell-
fate specification. Here, using single-cell transcriptomics, we
determined the extent of transcriptional heterogeneities be-
tween individual cells in pre-implantation embryos and identified
that target genes of the pluripotency master regulators Oct4 andCell 165, 61–74, March 24, 2016 ª2016 The Authors 61
Sox2 are highly heterogeneous at the 4-cell stage. We find that
Sox21, a Sox2 target that also displays proximal binding of
Oct4 and that regulates expression of themaster regulator of dif-
ferentiation Cdx2, is one of the most highly heterogeneous
genes at this stage. We also find that decreasing expression of
Sox21 in individual cells results in premature and increased
expression of Cdx2 and decreased contribution to the pluripo-
tent lineage. We identify CARM1, which methylates histone H3
at arginine 26 (H3R26), as an upstream regulator of Sox21
expression. These results indicate that heterogeneity in gene
expression patterns biases cell fate in the mouse embryo as
early as the 4-cell stage.
RESULTS
Temporal and Spatial Gene Expression Patterns in
Single Cells during Pre-implantation Development
To assess gene expression patterns throughout the pre-implan-
tation development of mouse embryos, we isolated individual
cells from successive stages and assayed their transcriptomes
using the Smart-Seq2 single-cell RNA-sequencing protocol (Pi-
celli et al., 2014). Transcriptomes were determined for all blasto-
meres of 28 embryos isolated at the 2-cell (n = 8), 4-cell (n = 16),
and 8-cell (n = 4) stages, and for individual cells at the 16-cell
(n = 6) and 32-cell (n = 6) stages, corresponding to the morula
and blastocyst, respectively (Figure 1A; Table S1). To assess
the quality of the data we compared, across cells in each batch,
three metrics: the fraction of reads mapped to endogenous RNA
molecules, the number of genes with more than 10 reads per
million, and the fraction of reads mapped to mitochondrial genes
(Stegle et al., 2015). One 32-cell stage sample failed our quality
check and was excluded from downstream analysis (Experi-
mental Procedures; Figure S1).
Extrinsic ‘‘spike-in’’ RNA-molecules were added to each cell’s
lysate prior to cDNA conversion, amplification, and library prep-
aration (Experimental Procedures). We applied principal compo-
nent analysis (PCA) to the log-transformed normalized read
counts from the spike-ins and, as expected, did not observe
any structure in the data (Figure S2). When we applied PCA to
the log-transformed normalized read counts of highly variable
genes from all cells analyzed, the cells grouped by develop-
mental stage (Figure 1B; Experimental Procedures), in accord
with previous results (Deng et al., 2014; Tang et al., 2011; Xue
et al., 2013).
To identify genes that are differentially expressed as develop-
ment progresses, we analyzed temporal gene expression pat-
terns throughout pre-implantation development. At a false dis-
covery rate (FDR) cutoff of 0.05, 2,716 genes were differentially
expressed between 2- and 4-cell, 3,222 between 4- and 8-cell,
2,030 between 8- and 16-cell, and 351 between 16- and 32-
cell embryos. Consequently, our data suggest that the transition
from the 4- to 8-cell stage is where most transcriptional changes
occur. To quantitatively assess intra- and inter-embryo hetero-
geneity in gene expression, we focused on the stages where
all individual cells could be collected from the same embryo
(the 2-, 4-, and 8-cell stages). We computed the correlation of
expression levels between all pairs of blastomeres within each
complete embryo (intra-embryonic correlation) and compared62 Cell 165, 61–74, March 24, 2016 ª2016 The Authorsthis to the correlation of blastomeres between different embryos
(inter-embryonic correlation). We found that intra-embryonic
correlation was significantly higher than the inter-embryonic cor-
relation for 2- and 4-cell embryos, while at the 8-cell stage no
statistically significant difference could be identified (Figure 1C;
Welch’s t test, p values are 8.5 3 105, 5.9 3 107 and 0.74
for the 2-, 4-, and 8-cell stage, respectively). Thus at the 2-
and 4-cell stages inter-embryonic variability is higher than the
transcriptional differences between cells of the same embryo.
Conversely, at the 8-cell stage the differences between cells in
the same embryo are comparable to those between cells from
different embryos, suggesting a relatively higher degree of
intra-embryonic heterogeneity. After correcting for inter-embryo
differences in expression levels, we identified genes displaying
significantly more intra-embryonic heterogeneity in expression
than expected by chance (Experimental Procedures). These an-
alyses revealed 659, 1,339, and 813 highly variable genes at 2-,
4-, and 8-cell embryos, respectively (Figures 1D and S3; Data
S1). Of these variable genes, 47 showed heterogeneous expres-
sion at all three stages (Table S2), 82 are shared between the 2-
and the 4-cell stage, 203 between the 4- and the 8-cell stage,
and 31 between the 2- and the 8-cell stage (Figure 1D).
Previous studies have shown that embryo development can
differ depending on the orientation and order of cell divisions
to the 4-cell stage (Gardner, 2002; Piotrowska-Nitsche and Zer-
nicka-Goetz, 2005), leading us to characterize gene expression
in embryos with different division patterns (Figure S4). PCA anal-
ysis of 16 4-cell embryos revealed that embryos with distinct cell
division patterns align approximately along the first principal
component (Figure 1E; Figure S4). Thus, cell division orientation
and order might be one of the factors contributing to gene
expression patterns in the 4-cell embryo. However, here we
focus on genes expressed highly heterogeneously between
cells in all individual embryos, independent of their cell division
pattern.
Sox21mRNA Expression Is Highly Variable at the 4-Cell
Stage and Correlates with the Expression of
Pluripotency-Related Genes
We reasoned that highly heterogeneous genes in the 4-cell em-
bryo were of particular interest as cells at this stage can display
differential fate (Piotrowska-Nitsche et al., 2005; Bischoff et al.,
2008; Plachta et al., 2011; Tabansky et al., 2013) and potential
(Piotrowska-Nitsche et al., 2005; Morris et al., 2012). One of
the most highly heterogeneous genes in all embryos analyzed
at the 4-cell stage is the gene encoding the transcription factor
Sox21 (Figure 2A), which is involved in regulating ES cell-fate
downstream of Sox2 (Kuzmichev et al., 2012; Mallanna et al.,
2010). Sox21 has not been previously studied in the early mouse
embryo but is known to inhibit expression of the trophectoderm
(TE) master gene Cdx2 in ES cells and is important for reprog-
ramming (Kuzmichev et al., 2012). Furthermore, Sox21 expres-
sion is directly regulated by Sox2 (Chakravarthy et al., 2011;
Kuzmichev et al., 2012; Mallanna et al., 2010), and its regulatory
region is bound by Oct4 (Chakravarthy et al., 2011; Go¨ke et al.,
2011), which has heterogeneous nuclear-cytoplasmic kinetics at
the 4-cell stage (Plachta et al., 2011). Together, this suggests
that the heterogeneous Sox21 expression may itself be
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Figure 1. Cellular Heterogeneity in Overall Gene Expression Patterns
(A) Scheme of development from the fertilized egg (zygote) to the blastocyst stage with three lineages: epiblast (EPI; blue), primitive endoderm (PE, red), and
trophectoderm (TE, green). The mechanism(s) initiating these cell-fate decisions remains unknown (reviewed in Zernicka-Goetz et al., 2009).
(B) Principal component analysis of the gene expression patterns of single cells at different stages. The percentage of variance explained by each principal
component is indicated in parentheses.
(C) Spearman correlation coefficients of blastomeres within the same embryo (intra-embryonic) and in different embryos (inter-embryonic) at the 2-, 4-, and 8-cell
stage. Asterisks indicate statistically significant differences (Welch’s t test).
(D) Venn diagram with the number of genes having a significantly high degree of heterogeneous expression at 2-, 4-, and 8-cell stages.
(E) Principal component analysis of the transcriptomes of cells from embryos at the 4-cell stage with different division patterns: ME, six embryos; EM, six
embryos; MM, three embryos; EE, one embryo. M, meridional; E, equatorial cell division.
See also Figures S1, S2, S3, and S4, Tables S1 and S2, and Data S1.regulated by heterogeneous Oct4 and/or Sox2 activity in the
embryo. To explore whether Oct4 and/or Sox2 could drive het-
erogeneity in gene expression, we next determined whether
their target genes are overrepresented in the ‘‘highly heteroge-neous’’ group of genes, and whether their expression correlates
with that of Sox21, which would be expected if they are regu-
lated by differential Oct4 and/or Sox2 activity in a cell-specific
manner.Cell 165, 61–74, March 24, 2016 ª2016 The Authors 63
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Figure 2. Heterogeneous Expression of Oct4 and Sox2 Target Genes at the 4-Cell Stage
(A) To find highly variable genes, we used the parameterization CV2 = a1/m + a0 to fit the relationship between the square of the coefficient of variation, CV
2, and the
average expression level m (green continuous curve; see Experimental Procedures for further details). All highly variable genes (with an adjusted p value < 0.1)
marked by red circles. Sox21, cyan circle.
(A0) The same information from (A) but with Oct4 and/or Sox2 targets indicated (diamonds mark shared Sox2 and Oct4 targets, squares mark Oct4 targets, and
triangles mark Sox2 targets). Gray symbols mark Oct4 and/or Sox2 targets that are not variable and blue symbols mark Oct4 and/or Sox2 targets that are highly
variable at the 4-cell stage. Sox21 is marked in gold.
(B) Heatmap showing the Spearman correlation coefficient among highly variable Oct4 and/or Sox2 targets. A dynamic tree cut algorithm identified two clusters
of genes showing similar patterns of correlations (colored side bars; Experimental Procedures).
See also Figure S5.We applied Fisher’s exact test to a list of Oct4/Sox2 down-
stream target genes (Experimental Procedures) and found that
they are indeed overrepresented in the set of highly variable
genes at the 4-cell stage (p value 33 1010; Figure 2A0). Further-
more, we found that a subset of highly variable Oct4/Sox2 target
genes are correlated with Sox21 (Figures 2B and S5), suggesting
coordinated expression of this module of genes at this stage.
Interestingly, this module includes known pluripotency-related
genes, such as Nanog and Esrrb, suggesting that Sox21 expres-
sion might be associated with a ‘‘more pluripotent’’ transcrip-
tional state.64 Cell 165, 61–74, March 24, 2016 ª2016 The AuthorsWhen we examined the mRNA expression of Sox21 through
time, we observed a peak at the 4-cell stage followed by down-
regulation from the 8-cell stage onward (Figure 3A). By contrast,
the expression of Esrrb and Nanog increases at the 8- and 16-
cell stages, respectively (Figure 3A). The expression pattern of
Sox21mRNAwas consistently highly variable, with a large differ-
ence in expression between the highest and lowest expressing
cells across all 4-cell embryos examined (Figure 3B; n = 64 cells,
16 embryos). Interestingly, in all cases there was at least one cell
in each embryowith very low or noSox21mRNA (Figure 3C). This
cellular heterogeneity in Sox21 expression was confirmed at the
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Figure 3. Sox21 mRNA and Protein Expression Is Heterogeneous and Peaks at the 4-Cell Stage
(A) Relative mRNA expression of Sox21, Nanog, and Esrrb.
(B) Average relative Sox21 mRNA levels in 4-cell embryos.
(legend continued on next page)
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protein level at both the late 4- and early 8-cell stages (Figure 3D;
n = 25 4-cell embryos and n = 23 8-cell embryos). These results,
together with the role of Sox21 in regulating ES cell fate (Kuzmi-
chev et al., 2012), led us to investigate whether heterogeneous
Sox21 expression might have functional consequences for
cell-fate specification in the embryo.
Live-Cell Tracking Demonstrates Cells with Decreased
Sox21 Expression Contribute More Extra-Embryonic
than Pluripotent Progeny
To determine whether heterogeneity in Sox21 expression influ-
ences cell fate, we decreased Sox21 expression using a combi-
nation of three Sox21 small interfering RNAs (siRNAs), which we
confirmed reduce Sox21 protein to undetectable levels (Fig-
ure 4A). To generate Sox21 heterogeneity, we injected these
siRNAs into single blastomeres at the late 2-cell stage alongside
mRNA for GFP as a lineage marker to follow a cell’s develop-
mental fate (Figure 4B). We allowed the embryos to develop for
72 hr, until the late blastocyst stage, and scored the lineage
contribution of each cell using molecular markers for each line-
age and cell position within the embryo (Figure 4C). Cells with
decreased Sox21 expression were significantly more likely to
initiate differentiation and contribute to the extra-embryonic TE
lineage (p < 0.001) than cells injected with control siRNA, and
correspondingly significantly less likely to contribute to pluripo-
tent inner cell mass (ICM) lineages (p < 0.01, Figure 4D, n = 75
and n = 38 embryos for Sox21 siRNA and control, respectively).
When we injected each Sox21 siRNA individually, the same
phenotype was observed (Figure S6), indicating that the pheno-
type is specific to decreased Sox21 expression and not due to
off-target effects.
Segregation of the TE and ICM occurs primarily as a result of
asymmetric cell divisions at the 8–16 and 16–32 cell transitions,
which contribute one daughter cell to the TE and one to the ICM
(Fleming, 1987; Johnson and Ziomek, 1981; Morris et al., 2010;
Watanabe et al., 2014). Inside cells can also be generated by api-
cal constriction or cell engulfment (McDole et al., 2011; Morris
et al., 2012; Parfitt and Zernicka-Goetz, 2010; Samarage et al.,
2015; Yamanaka et al., 2010). To determine the cellular mecha-
nism bywhich cells with decreased Sox21 expression contribute
to the TE, we injected one blastomere of 2-cell embryos with
three Sox21 siRNAs, or control siRNA, together with mRNA for
a GFP-tagged membrane-bound protein (Gap43-GFP) as a
marker, and filmed development of the embryos by time-lapse
microscopy (Figures 4E and 4F; n = 18 embryos, 288 cells for
control siRNA and n = 16 embryos, 256 cells for Sox21 siRNA).
Live-cell tracking of all Gap43-GFP-expressing cells revealed
that, by the early blastocyst (32-cell) stage, control siRNA blasto-
meres had generated an average of 10.9 outside cells and 5.1
inside cells (Figure 4G), with an average of 4.41 asymmetric divi-
sions and 0.69 cells internalized by cell engulfment (Figures 4H
and 4I). In contrast, the Sox21 siRNA blastomeres had generated(C) Relative Sox21 mRNA expression in all individual 4-cell embryos.
(D) Immunofluorescence of Sox21 in 4-cell (n = 25) and 8-cell (n = 23) embryos.
Fluorescence quantified and normalized to the nucleus with the strongest staining
cell. Asterisks indicated lowest expressing cells. Error bars represent SEM. Scal
66 Cell 165, 61–74, March 24, 2016 ª2016 The Authorsan average of 13.7 outside cells and only 2.3 inside cells, with
significantly fewer asymmetric divisions (an average of 2.3) by
the same stage (p < 0.001; Figures 4G, 4H, and 4J). Therefore,
cells with lower Sox21 expression undertake fewer asymmetric
cell divisions and contribute more extra-embryonic rather than
pluripotent progeny.
Decreased Expression of Sox21 Results in Premature
and Increased Expression of Cdx2
Correct differentiation into extra-embryonic TE requires the tran-
scription factor Cdx2 (Jedrusik et al., 2008; Strumpf et al., 2005).
As Sox21 has been shown to bind to an enhancer of Cdx2 and
repress its expression in ES cells (Kuzmichev et al., 2012), we
next investigated whether Sox21 might also regulate Cdx2 in
the embryo. To this end, we first decreased expression of
Sox21 at the zygote stage, by injecting a mixture of three
siRNAs as before, and examined the developmental timing and
level of Cdx2 expression. Decreased expression of Sox21 re-
sulted in a significant increase in Cdx2 mRNA expression at
the 8-cell stage, compared to control siRNA embryos (Figures
5A and 5B; p < 0.05; n = 85 and n = 75 embryos for Sox21 siRNA
and control, respectively, three biological replicates). When we
repeated the experiment by downregulating Sox21 in the zygote
but now examined Cdx2 protein at the early 8-cell stage, when
Cdx2 protein is normally not yet detectable, we found that all
embryos in which Sox21 expression was decreased already ex-
pressed Cdx2 protein (Figures 5C and 5D; n = 96 cells [84 Cdx2-
positive cells, 87.5%], 12 embryos for the experimental group
and n = 88 cells [11 Cdx2-positive cells, 12.5%], 11 embryos
for the control group).
Finally, to test the functional consequences of heterogeneous
Sox21 expression on Cdx2 expression, we decreased Sox21 in
just half of the embryo, from the 2-cell stage onward, using
Gap43-RFP as a lineage marker (Figures 5E and 5F). This re-
sulted in a significant upregulation of Cdx2 in the half of the em-
bryo in which cells had decreased Sox21 expression (Figure 5G;
p < 0.001; n = 104 cells, 13 embryos and n = 88 cells, 11 embryos
for the experimental and control groups, respectively). Together,
these results suggest that cells with lower Sox21 levels are the
first to upregulate Cdx2 (mRNA and protein) and therefore are
first to initiate development into the extra-embryonic TE lineage.
Sox21 Expression Is Regulated by CARM1 Activity
Since our results indicate that heterogeneity in Sox21 expression
could bias cell fate in the early embryo, we sought to determine
the upstream regulators of this heterogeneity. One factor we pre-
viously found to be heterogeneous at the 4-cell stage is histone
H3R26 methylation mediated by CARM1, which itself is hetero-
geneously active at the 4-cell stage (Torres-Padilla et al.,
2007). Furthermore, elevated CARM1 expression leads to
increased histone H3R26me and contribution to the ICM
(Torres-Padilla et al., 2007; Wu et al., 2009). To determineper individual 4-cell or 8-cell embryo. Arrowheads indicate highest expressing
e bars, 10 mm.
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Figure 4. Decreasing Sox21 Expression Leads Cells to an Extra-Embryonic Fate
(A) Verification ofSox21 siRNA efficiency at the 4-cell stage (Control siRNA n = 20,Sox21 siRNA n = 21). The nuclear immunofluorescence signal is lost in embryos
injected with Sox21 siRNA.
(B) Scheme of clonalSox21 siRNA. One blastomere of 2-cell stage embryos injectedwithSox21 siRNA or control siRNA, andGFPmRNA. Embryos cultured to the
late blastocyst stage and the contribution of the injected cells’ progeny to each lineage analyzed.
(legend continued on next page)
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whether altering CARM1 activity affects the expression of
Sox21, we first treated embryos with a CARM1-specific inhibitor
from the 2-cell stage. To test its effectiveness, we determined
the levels of histone H3R26me after 10 hr of treatment and
observed it to be reduced to an undetectable level (Figure 6A).
Inhibition of CARM1 resulted in a complete loss of Sox21 expres-
sion at the 4-cell stage (Figure 6B, n = 21 control; n = 15 CARM1
inhibition). To downregulate CARM1 through an alternative
mechanism, we injected Carm1 siRNA into zygotes and cultured
embryos until the blastocyst stage. Decreasing CARM1 expres-
sion resulted in a significant reduction in the number of pluripo-
tent epiblast cells with a concurrent increase in the number of
primitive endoderm cells and no effect on the TE lineage (Figures
6C and 6Dp < 0.001; n = 12 control; n = 8Carm1 siRNA). To over-
express CARM1, we injected synthetic mRNA for CARM1 into
zygotes. CARM1 upregulation led to a significant upregulation
of Sox21 mRNA expression at the 8-stage, as well as increased
expression of other pluripotency genes, including Sox2 and
Nanog (Figure 6E; p < 0.01 and p < 0.05; n = 75 embryos and
n = 66 embryos for CARM1 mRNA and control, respectively,
three biological replicates). These results indicate that CARM1
activity regulates expression of a number of pluripotency regula-
tors including Sox21 in the 4-cell embryo.
DISCUSSION
When heterogeneity in gene expression patterns first arises
during the development of the mammalian embryo and how
this might influence cell fate have remained, thus far, unknown.
Approaching these questions has been difficult because of the
inherent developmental flexibility of the embryo and because of
previous technical limitations that prevented accurate quantifica-
tion of gene expression levels in individual cells as development
progresses. Although it has previously been thought that cells are
homogenous until generation of inside and outside cells, more
recent studies have opened a new possibility that cells at the
4-cell stage can already exhibit differences in cell fate (Piotrow-
ska-Nitsche et al., 2005; Tabansky et al., 2013) and develop-
mental potential (Morris et al., 2012; Piotrowska-Nitsche et al.,
2005). This led to the suggestion that the differential activity of
epigenetic regulators such as CARM1 (Torres-Padilla et al.,
2007) or PRDM14 (Burton et al., 2013), or the differential behavior
of transcription factors such as Oct4 (Plachta et al., 2011), at the
4-cell stage could be linked to differential cell fate and potential.
Here, we sought to address this by first investigating and directly
comparing global differences in gene expression between indi-(C) Confocal images of control (n = 38) and Sox21 (n = 75) siRNA embryos. Sox17
mark the ICM.
(D) Contribution of Sox21 siRNA cells to TE, PE, and EPI, relative to control siRN
(E) Time-lapse study following Sox21 siRNA (n = 16 embryos, 256 cells) or cont
tomeres injected with either control or Sox21 siRNA. Fluorescence images are o
(F) Example slice through embryos showing inside and outside cell fate of either
(G) Number of inside and outside cells contributed from injected blastomeres at
(H) Number of asymmetric divisions injected blastomeres underwent from the 8-
(I and J) Lineage trees from two representative embryos. All injected cells were t
when enclosed from the outside environment by neighboring cells. Inside or outs
Error bars represent SEM. Wilcoxon rank-sum test was used to test significance
68 Cell 165, 61–74, March 24, 2016 ª2016 The Authorsvidual cells within the embryo during the first days of develop-
ment. Focusing on the transcriptomes of each and every cell in
16 4-cell stage embryos uncovered consistent patterns of highly
heterogeneous gene expression, with the most heterogeneously
expressedgenesbeing targets ofSox2andOct4, amongwhich is
the gene for the transcription factor Sox21.
The role of Sox21 in the early embryo has not been previously
investigated, but studies in ES cells indicated its involvement in
stem cell differentiation, the inhibition of Cdx2 expression, and
cellular reprogramming (Mallanna et al., 2010, Kuzmichev
et al., 2012). The regulatory regions of theSox21 gene are targets
of Oct4 binding, and its expression is regulated by Sox2 (Chak-
ravarthy et al., 2011; Go¨ke et al., 2011; Kuzmichev et al., 2012;
Mallanna et al., 2010). Among other target genes of Oct4 and/
or Sox2 showing similar heterogeneity of expression, we identi-
fied those for pluripotency transcription factors such as Nanog
and Esrrb; however, their expression peaked later than that of
Sox21, suggesting that Sox21 could play a role very early in
development. Indeed, our finding that expression of Sox21 re-
presses premature differentiation in the embryo accords with
the finding that Sox21 is essential for reprogramming in vitro
(Kuzmichev et al., 2012). However, Sox21mutant mice are viable
(Kiso et al., 2009). One possible explanation of this paradox
could be that Sox21 is part of a functionally redundant mecha-
nism typical of crucial biological processes and of importance
in the regulative development of mammalian embryos. Hetero-
geneous expression of Sox21, along with other co-regulated
genes, could also set up a competitive advantage between blas-
tomeres during early development without being essential. Thus,
while embryos may not have an absolute requirement for Sox21,
heterogeneous Sox21 expression levels could lead to biased
cell-fate decisions. We tested this possibility by setting up clonal
differences in Sox21 levels experimentally. This revealed that
clones of cells with decreased Sox21 expression contribute
more differentiated TE rather than pluripotent progeny via a
decreased frequency of asymmetric cell divisions. It has been
previously shown that the frequency of symmetric to asymmetric
cell divisions can be altered by the expression of the TE-specific
transcription factor Cdx2 (Jedrusik et al., 2008). In agreement,
we find that decreased Sox21 expression leads to elevated
expression of Cdx2 at the 8-cell stage. This can be explained
by noting that Sox21 binds to the Cdx2 enhancer in stem cells
to negatively regulate its expression (Kuzmichev et al., 2012).
In addition, depletion of Sox21 in the whole embryo leads to
earlier expression of Cdx2. Thus, in the case of uniform Sox21
depletion, there are no heterogeneities present and thus no(primitive endoderm, PE) and Cdx2 (TE) used as lineage markers. Dotted lines
A cells.
rol siRNA (n = 18 embryos, 288 cells). Gap43-GFP expression indicates blas-
verlaid with cell-tracking spheres.
control or Sox21 siRNA blastomeres.
the 32-cell stage.
to 32-cell stage.
raced to the 32-cell stage. A cell was defined as occupying an inside position
ide cell fate indicated.
**p < 0.01, ***p < 0.001. Scale bars represent 10 mm. See also Figure S6.
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Figure 5. Sox21 Depletion Prematurely Upregulates Cdx2 Expression
(A) Scheme of Sox21 siRNA experiment. Zygotes injected with Sox21 siRNA, or control siRNA, and isolated at the 8-cell stage for immunostaining or qRT-PCR.
(B) qRT-PCR of embryos injected with either control siRNA (n = 75 embryos, three biological replicates) or Sox21 siRNA (n = 85 embryos, three biological
replicates) comparing mRNA expression of Cdx2 and Sox21 at the late 8-cell stage. Student’s t test was used to test significance *p < 0.05, ***p < 0.001.
(C) Confocal images of Cdx2 and Histone H3 expression in control (n = 12) and Sox21 (n = 12) siRNA embryos at the early 8-cell stage.
(legend continued on next page)
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bias in cell fate. These results suggest that Sox21 expression in
the 4-cell embryo might help to safeguard against the premature
initiation of differentiation.
Howmight the heterogeneous expression of Sox21 first arise?
It is possible that the Sox21 heterogeneity we identify here is
generated by random transcriptional differences; however, we
wished to investigate whether this differential expression could
be regulated by factors previously found to be heterogeneous
at the 4-cell stage. Our best candidate for the heterogeneous
regulation of Sox21 was methylation of histone H3R26 because
we have previously found that CARM1, which mediates this
modification, regulates the expression of pluripotency genes
and is differentially active in the 4-cell embryo (Torres-Padilla
et al., 2007). We find here that inhibiting CARM1 activity results
in a loss of Sox21 expression in 4-cell embryos and, in contrast,
its upregulation causes an increase in expression of Sox21 and
the pluripotency genes Sox2 and Nanog at the 8-cell stage.
Therefore, differential activity of CARM1 in the 4-cell embryo is
likely to be responsible for the differential expression of Sox21.
We also show that by decreasing CARM1 expression we signif-
icantly reduce the number of pluripotent epiblast cells, indicating
the critical role of CARM1 for maintaining the pluripotent state
in the ICM. How CARM1 becomes heterogeneous remains an
open question. The work presented here shows that CARM1
overexpression does not affect Oct4 mRNA expression, sug-
gesting that the regulation of Sox21 by CARM1 is not achieved
through transcriptional regulation of Oct4. This, however, does
not exclude the possibility that CARM1 is indirectly affecting
Oct4 or Sox2 activity. It can be hypothesized that increased
levels of CARM1, resulting in increased histone H3R26me, could
influence Oct4 and/or Sox2 DNA binding and lead to the upregu-
lation of Oct4 and/or Sox2 target genes (Figure 7). Indeed, Oct4
expression is not heterogeneous at the 4-cell stage and its
different DNA binding dynamics in individual cells might be due
to differential accessibility to target genes (Plachta et al., 2011).
In conclusion, we suggest that highly heterogeneous expres-
sion of several Oct4 and/or Sox2 targets within the 4-cell
embryo, regulated by differential activity of CARM1, creates
heterogeneities that bias cell fate toward either an embryonic
(pluripotent) or extra-embryonic (differentiating) fate. We further
suggest that the highly heterogeneous expression of Sox21 is
one of a number of mechanisms available to the embryo to direct
cell fate. Our findings that several Oct4 and Sox2 target genes
are overrepresented in the subset of highly variable genes at
the 4-cell stage and that Sox21 is co-regulated with other tran-
scription factors, such as Nanog and Esrrb, supports this hy-
pothesis. Thus, if a single source of heterogeneity were to be
removed, the embryo could compensate for this loss. In sum-
mary, our results indicate that heterogeneous gene expression
as early as the 4-cell stage initiates cell-fate decisions.(D) Quantification of the number of Cdx2 positive cells from (C). Student’s t test
(E) Scheme of Sox21 siRNA experiment. One blastomere of 2-cell stage embryos w
8-cell embryos isolated.
(F) Confocal images of Cdx2 and Histone H3 expression in late 8-cell stage embry
(n = 11) or Sox21 siRNA (n = 13). Gap43-RFP expression on the membrane iden
(G) Quantification of relative fluorescence intensity of Cdx2 staining from (F).
Wilcoxon rank-sum test was used to test significance ***p < 0.001. Scale bars, 1
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Collection of Mouse Embryos and Cells
All animal experiments were performed in compliance with Home Office regu-
lations. Embryos were recovered from superovulated F1 (C57Bl6xCBA) fe-
males into M2 media supplemented with 4% BSA, as described previously
(Piotrowska et al., 2001). Individual cells were collected at late 2-cell (48 hr after
hCG), late 4-cell (10 hr after the first 2-cell blastomere divided), late 8-cell (10 hr
after the first 4-cell blastomere divided), 16-cell (78 hr after hCG), and 32-cell
(86 hr after hCG) stages. Embryos for cell isolation at the 2-, 4,- and 8-cell
stages were collected at the 2-cell stage and cultured in KSOM media (Milli-
pore) at 37C with 5% CO2. Embryos for the 16- and 32-cell blastomeres
were collected directly at the respective stages. The zona pellucida was
removed using Tyrode’s solution (Sigma). Zona-free embryos were incubated
for 5 min (for the 2-, 4-, and 8-cell stages) or 20 min (for the 16- and 32-cell
stages) in Ca2+ and Mg2+ free M2 before disaggregation by careful pipetting.
Each embryo was processed individually. Single blastomeres were placed
into individual tubes containing 2.3 ml of 0.2% Triton X-100 (Sigma) supple-
mented with 1 U/ml RNAsIN (Ambion).
Scoring 2- to 4-Cell Division Pattern
At the late 2-cell stage, one cell was injected with rhodamine-dextran (Invitro-
gen), as described previously (Bischoff et al., 2008). Embryos were observed
at 20 min intervals to categorize the division order and orientation, meridional
(M) or equatorial (E), relative to the position of the second polar body. 4-cell
embryos were sorted into ME, EM, EE, and MM groups. Embryos with absent
or unattached polar body were discarded. Following disaggregation, the cells
were inspected under an epifluorescent microscope and classified as origi-
nating from the first- or second-dividing 2-cell blastomere based on the rhoda-
mine fluorescence.
RNA Sequencing and Mapping of Reads
mRNA from the single cells was amplified using the SMARTSeq2 protocol (Pi-
celli et al., 2014), with the additional inclusion of ERCC spike-in control (1 ml of
1:250,000 [batches 1 and 2] or a 1:1,000,000 [batch 3 and batch 4] dilution of
mix 1 [Ambion] per cell). Multiplex sequencing libraries were generated from
amplified cDNA using Nextera XT (Illumina) and sequenced on a HiSeq 2500
running in rapid mode. Paired-end reads were mapped simultaneously to
the M. musculus genome (Ensembl v.38.77) and the ERCC sequences using
GSNAP (v.2014-10-07) with default parameters. Htseq-count (Anders et al.,
2015) was used to count the number of reads mapped to each gene (default
options).
Quality Assessment of Cells
To assess the quality of the data, three metrics were used: the fraction of map-
ped reads, the number of geneswithmore than 10 reads permillion (RPM), and
the fraction of reads mapped to mitochondrial genes. Figures S1A–S1C show
thesemetrics as functions of the total number of reads for each cell. When PCA
was carried out using these three quantities, cells that perform worse than the
average according to all three criteria appear as outliers (Figure S1D). One
clear outlier was found (black arrow in all four panels) and was excluded
from downstream analyses (sample name ‘‘32cell_F’’, see Table S1 for a list
of samples).
Normalization of Read Counts and Analysis of Spike-ins
The data were divided into two groups according to whether they were map-
ped to ERCC spike-ins or to endogenous genes. For each of these groups awas used to test significance ***p < 0.001.
as injected with Sox21 siRNA or control siRNA andGap43-RFPmRNA and the
os after injection of one blastomere at the 2-cell stage with either control siRNA
tifies injected cells.
0 mm. Error bars represent SEM.
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Figure 6. Sox21 Expression Is Regulated by
CARM1 Activity
(A) Verification of CARM1 inhibition by staining for
the presence of H3R26me (control n = 21, CARM1
inhibition n = 15). Scale bars, 20 mm.
(B) Confocal images of Sox21 expression in 4-cell
embryos after being treated from the 2-cell
stage with either DMSO control (n = 27) or CARM1
inhibitor (n = 24). Scale bar, 50 mm.
(C) Confocal images of control (n = 12) and Carm1
siRNA (n = 8) embryos. Sox17 (PE), Cdx2 (TE), and
Nanog (EPI) used as lineage markers. Scale bars,
10 mm.
(D) Overall number of TE, PE, and EPI cells present
in Carm1 siRNA-injected embryos, relative to
control siRNA cells. Student’s t test was used to
test significance ***p < 0.001.
(E) qRT-PCR of embryos injected with either con-
trol mRNA (n = 66 embryos, three biological rep-
licates) or CARM1 mRNA (n = 75 embryos, three
biological replicates).
Embryos injected at the zygote stage and isolated
for qRT-PCR at the late 8-cell stage Student’s
t test was used to test significance *p < 0.05,
**p < 0.01. Error bars represent SEM.set of size factors (Love et al., 2014) was calculated and used to normalize
the raw read counts. While the size factors calculated with ERCC spike-ins
account for sequencing depth, the size factors calculated on endogenous
genes also normalize for the amount of RNA obtained from each cell (Bren-
necke et al., 2013), which is highly correlated with cell cycle stage (Buettner
et al., 2015).
Differential Expression Analysis
First, genes with an average expression level of less than 50 normalized read
counts across the two groups of cells compared were removed. The Bio-
conductor package DESeq2 (Love et al., 2014) was then used to find sets ofCell 165, 61–differentially expressed genes. An FDR of 0.05
was used as a threshold for significance. To avoid
confounding effects due to embryos being
collected in different batches, when comparing
blastomeres from different stages, we used only
embryos at 2-, 4-, 8-, 16-, and 32-cell stages
from the same batch (batch 1, see Table S1 for a
list of samples).
Highly Variable Genes
To identify highly variable genes across all
cells collected, we applied the method
described in Brennecke et al. (2013) by fitting
the squared coefficient of variation CV2 as a
function of the mean normalized counts m with
the parameterization CV2 = a1/m + a0. To mini-
mize the skewing effect due to lowly expressed
genes, only genes with a mean normalized count
greater than 10 were used. Genes with an
adjusted p value (Benjamini-Hochberg method)
less than 0.1 were considered as significantly
highly variable.
Adjusting for Batch Effects
The technical variation between samples in
different batches was removed using the ComBatfunction in the R package ‘‘sva’’ with default options (Johnson et al., 2007). A
log10 transformation was first applied to normalized read counts (by sum-
ming 1 to avoid infinities) and lowly expressed genes (less than 10 normal-
ized read counts on average) were removed. ComBat was used to adjust
for batch effect with the known batch covariate, controlling for sample stage
and cell division pattern. All expression values that were 0 or negative after
batch effect removal were set to 0. These batch-adjusted expression values
were used to perform PCA on the highly variable genes. The results do not
significantly change if different criteria are adopted to select genes (e.g.,
union of 1,000 or 5,000 most highly expressed genes, 3,000 genes with high-
est average expression).74, March 24, 2016 ª2016 The Authors 71
Figure 7. Model of How Cellular Heterogeneities at the 4-Cell Stage Regulate Cell Fate
(A–C) In 4-cell embryos, CARM1, which methylates histone H3R26, is differentially expressed (Torres-Padilla et al., 2007). We hypothesize that higher levels of
histoneH3R26me facilitate the binding toDNAof pluripotency regulators such asOct4 andSox2, resulting in increased transcription of pluripotency-related target
genes, such as Sox21, Nanog, and Esrrb, biasing these cells to contribute to the pluripotent lineage. Conversely, in cells with lower levels of histone H3R26me,
pluripotency regulators are only able to bind to DNA for shorter periods of time, and therefore their target genes are not as highly expressed. These cells
have lower levels of pluripotency and are thus more likely to initiate expression of differentiation genes, such as Cdx2, and initiate development into the extra-
embryonic TE.Analysis of Inter- and Intra-embryonic Heterogeneity
To identify genes that show a significantly high variability across blastomeres
in the same embryo, we first regressed out the embryo effect by fitting the
linear model:
gijk =Ai +Bik + εijk
where gijk is the log-expression value of the gene i in cell j and embryo k, Ai is
the average log-expression of gene i across all cells,Bik represents the embryo
effect and εijk is the fit residual. The expression level of the gene with the em-
bryo effect removed, bgijk , is equal to gijk  Bik . We then applied the method
described above to the bgijk to identify highly variable genes.
The intra- and inter-embryonic transcriptional differences were quantified
and compared between blastomeres by computing Spearman’s correlation
coefficient between all pairs of blastomeres within the same embryo and in
different embryos at 2-, 4-, and 8-cell stage. Genes with a mean normalized
count less than 10 were removed. Only embryos collected in the same batch
were used for the calculation of inter-embryonic correlations (Table S1 for a list
of samples).
Testing for Enrichment of Oct4 and Sox2 Targets among Highly
Variable Genes
We downloaded a list of Oct4 target genes identified in three different publica-
tions (Loh et al., 2006; Matoba et al., 2006; Sharov et al., 2008) and selected
only those that were targeted by Oct4 in at least two out of three publications.
After removing all genes that were never expressed in our data, we tested the
significance of the association between the Oct4 target genes and highly var-
iable genes in 2-, 4-, and 8-cell embryos by Fisher’s exact test (p values are,
respectively, 0.005, 109 and 4 3 106). Analogously, we tested the enrich-
ment of Sox2 target genes (Sharov et al., 2008) among the highly variable
genes and found statistical significance at the 2- and 4-cell stages (p values
0.004 and 105), but not at the 8-cell stage (p value 0.26). Finally, the enrich-
ment test run on genes targeted by Oct4 and/or Sox2 gave the following72 Cell 165, 61–74, March 24, 2016 ª2016 The Authorsp values for embryos at 2-, 4-, and 8-cell stage, respectively: 2 3 104, 3 3
1010, and 3 3 105.
We focused on genes that are highly variable at the 4-cell stage and are tar-
geted by Oct4 and/or Sox2 (including Sox21 [Chakravarthy et al., 2011; Go¨ke
et al., 2011]) and searched for subsets of genes whose expression patterns
are coordinated. To this aim, the matrix of pairwise Spearman correlation co-
efficients was computed and hierarchical clusteringwas carried out (R function
‘‘hclust,’’ default options). TheDynamic TreeCut algorithmwas used to identify
clusters of genes (Langfelder et al., 2008) with the R function ‘‘cutreeDynamic’’
in the ‘‘dynamicTreeCut’’ package (default parameters).
Functional Assays
To downregulate Sox21, three Sox21-specific siRNAs (QIAGEN) at a total
(combined or individual) concentration of 12 mM were injected together with
GFP,Gap43-GFP, orGap43-RFPmRNA (400 ng/ml). AllStars Negative Control
siRNA (QIAGEN) was used as a control. The sequences of the siRNAs used
are as follows: Sox21 siRNA 1: 50-CCCGGTTTGTATGTACATAGA-30, Sox21
siRNA 2: 50-TACTCTGATTGTACTGTTGAA-30, Sox21 siRNA 3: 50-TTGTAT
GTACATAGATGTATA-30. To inhibit CARM1 activity embryos were treated
from the 2- to 4-cell stage with a chemical inhibitor against CARM1 (Millipore,
catalog no. 217531). CARM1 inhibitor was dissolved in DMSO (final concentra-
tion of DMSO was 0.005%) and used at a concentration of 9 mM in KSOM.
Control embryos were incubated in the equivalent DMSO concentration but
in the absence of the inhibitor. To downregulate CARM1 expression,
CARM1 stealth siRNAs (Life Technologies - AM16708) were injected at a con-
centration of 200 nM together with Gap43-RFP mRNA (200 ng/ml). CARM1
mRNA was prepared and microinjected as previously described (Torres-Pa-
dilla et al., 2007) at a concentration of 500 ng/ml. Embryos were cultured in
KSOM under paraffin oil at 37.5C in a 5% CO2.
Immunofluorescence
Primary antibodies used were goat anti-Sox17 (R&D Systems), rabbit anti-
Nanog (Abcam), mouse anti-Cdx2 (Biogenex), rabbit anti-Histone H3 (Abcam),
rabbit anti-Sox2 (Cell Signaling Technology), rabbit anti-Sox21 (R&D Sys-
tems), and rabbit anti-Histone H3 (symmetric di methyl R26; Abcam). ME
embryoswere used for Sox21 protein quantification at the 4- and 8-cell stages.
Immunofluorescence was carried out as described previously (Jedrusik et al.,
2008). Multichannel images were acquired using a Leica SP5 confocal micro-
scope, and confocal z stacks were exported to IMAGEJ for image processing,
intensity measurements and cell counting. Quantification of fluorescence in-
tensity was done by normalizing to Histone H3 staining and layer-normalizing
using the built-in ImageJ function. Intensity was measured in the normalized
sections using the ImageJ measure function.
Live Imaging
Following injection with siRNA, embryos were observed on an inverted epi-
fluorescent Zeiss Axiovert 200M microscope with a 203/0.75 NA objective.
Two-channel (green fluorescence and transmitted light) multisection images
were acquired every 30 min with a Hamamatsu ORCA ER CCD camera on
16 focal planes every 6 mm, with an exposure of 10 ms for transmitted light
and 50 ms for fluorescence. Simi Biocell software was used for cell tracking,
as previously described (Bischoff et al., 2008). Cell identification and lineage
rendering was done with MovIT software (from the BioEmergences platform).
qRT-PCR
Total RNA was extracted from 8-cell stage embryos using the Arcturus
PicoPure RNA isolation kit (Arcturus Bioscience). qRT-PCRwas carried out us-
ing SYBR Green in a StepOne Plus Real-time PCR machine (Applied Bio-
systems). Gapdh was used as an endogenous control. Relative mRNA con-
centrations were calculated using the ddCT method. The following primers
were used: Gapdh forward, 50-AGAGACGGCCGCATCTTC-30 and reverse,
50-CCCAATACGGCCAAATCCGT-30; Cdx2 forward, 50-AAACCTGTGCGAG
TGGATG-30 and reverse, 50-TCTGTGTACACCACCCGGTA-30; Sox21 forward,
50-GCCGGTGACTCGTGTCTTTA-30 and reverse, 50-GAACGGCGGTCATCT
CTCAT-30; Nanog forward, 50-GGTTGAAGACTAGCAATGGTCTGA-30 and
reverse, 50-TGCAATGGATGCTGGGATACT 30; Oct3/4 forward, 50-TTGGGC
TAGAGAAGGATGTGGTT-30 and reverse, 50-GGAAAAGGGACTGAGTAGAGT
GTGG-30; Sox2 forward, 50-CCATCCACCCTTATGTATCCAAG-30 and reverse,
50-CGAAGGAAGTGGGTAAACAGCAC-30.
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